Lipocine Inc. announced the promotion of Gregory Bass to the newly created position of Executive Vice President and Chief Commercial Officer reporting to Dr. Mahesh Patel, President and Chief Executive Officer.  Mr. Bass will be responsible for leading the commercialization of Lipocine’s product candidates, including its testosterone replacement franchise.  He joined Lipocine in 2016 and has served as its Vice President of Market Access since that time. Mr. Bass has over 20 years of experience in pharmaceutical and biopharmaceutical sales, marketing and market access with a consistent track record of improving operating performance and delivering value across a broad range of leadership roles in therapeutic categories at Pfizer and Johnson & Johnson.